Delving into the Latest Updates on Shanghai Chunxiang Medical Technology Co., Ltd. with Synapse

Overview

Tags

Digestive System Disorders

Infectious Diseases

Herbal medicine

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

No Data

Disease Domain	Count

Infectious Diseases	1

Top 5 Drug Type	Count

Herbal medicine	1

[Translation] A multicenter, randomized, double-blind, placebo-controlled, multiple-dose phase IIa clinical trial to evaluate the safety/tolerability and efficacy of different doses of oral Jiuwei Jinqiao Granules combined with antibiotics for the conservative treatment of acute simple appendicitis (heat toxicity, qi stagnation and blood stasis syndrome)

以―随访结束时的痊愈率‖为主要疗效指标，采用随机、双盲单模拟、安慰剂对照、多中心临床试验设计，评价九味金翘颗粒联合抗生素用药对急性单纯性阑尾炎患者的安全性/耐受性和有效性的临床试验，并进行初步的剂量探索。

[Translation]

Taking "cure rate at the end of follow-up" as the main efficacy indicator, a randomized, double-blind, single-dummy, placebo-controlled, multicenter clinical trial design was adopted to evaluate the safety/tolerability and efficacy of Jiuwei Jinqiao Granules combined with antibiotics in patients with acute simple appendicitis, and conduct preliminary dose exploration.

Start Date-

Sponsor / Collaborator

Shanghai Chunxiang Medical Technology Co., Ltd.

100 Clinical Results associated with Shanghai Chunxiang Medical Technology Co., Ltd.

Login to view more data

0 Patents (Medical) associated with Shanghai Chunxiang Medical Technology Co., Ltd.

Login to view more data

100 Deals associated with Shanghai Chunxiang Medical Technology Co., Ltd.

Login to view more data

100 Translational Medicine associated with Shanghai Chunxiang Medical Technology Co., Ltd.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 12 Jun 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Phase 2 Clinical

1

Login to view more data